INSM · Insmed Inc
United States · RS rating 44 · As of 2026-11-03
| Price | 104.44 USD |
|---|---|
| 1-day change | -4.5% |
| RS rating (overall / 1M / 3M / 12M) | 44 / 59 / 77 / 24 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 36 / 10 / 20 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +12.0% |
| Sales growth Q/Q | +85.4% |
| Distance from 52-week high | +50.6% |
| Market cap (USD) | $31.0B |